Neurology Central

Glioblastoma: could a blood test be on the horizon?


A team of scientists from the University of Sussex (UK) has identified novel biomarkers within the blood that may be used to diagnose glioblastoma.

Within the study, which has been published in Communications Biology, the researchers describe particular biomarkers that are associated with extracellular vesicles.

Previous studies have noted that small extracellular vesicles (sEVs) associated with tumors may be accessible in biofluids. However, more recently, studies have also implicated that sEVs could contain valuable biomarkers for patients with glioblastoma in terms of diagnosis and follow-up.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.